Efficacy and safety of aprotinin in neonatal congenital heart operations

Annals of Thoracic Surgery

Volumn 92, Issue 3, 2011, Pages 958-963

  Wilder, Nicole S ^a   Kavarana, Minoo N ^a   Voepel Lewis, Terri ^a   Paugh, Theron ^a   Lee, Timothy ^a   Ohye, Richard G ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; APROTININ; CREATININE; HEPARIN; TRANEXAMIC ACID;

ANTICOAGULANT THERAPY; ARTICLE; ASSISTED VENTILATION; BODY WEIGHT; CARDIOPULMONARY BYPASS; CLINICAL EFFECTIVENESS; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GESTATIONAL AGE; HUMAN; KIDNEY FAILURE; KIDNEY INJURY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; OPERATION DURATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAFETY; SEIZURE; TREATMENT OUTCOME;

APROTININ; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART DEFECTS, CONGENITAL; HEMOSTATICS; HOSPITAL MORTALITY; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; INTRAOPERATIVE PERIOD; LENGTH OF STAY; MALE; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80052806756     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.04.094     Document Type: Article

References (40)

1. J.H. Levy, and K.A. Tanaka Inflammatory response to cardiopulmonary bypass Ann Thorac Surg 75 2003 S715 S720
2. J.J. Jaggers, M.C. Neal, P.K. Smith, R.M. Ungerleider, and J.H. Lawson Infant cardiopulmonary bypass: a procoagulant state Ann Thorac Surg 68 1999 513 520 (Pubitemid 29521102)
3. E.C. Vamvakas, and M.A. Blajchman Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention Blood 113 2009 3406 3417
4. J. Lavee, N. Savion, A. Smolinsky, D.A. Goor, and R. Mohr Platelet protection by aprotinin in cardiopulmonary bypass: electron microscopic study Ann Thorac Surg 53 1992 477 481
5. R.C. Landis, D.O. Haskard, and K.M. Taylor New antiinflammatory and platelet-preserving effects of aprotinin Ann Thorac Surg 72 2001 S1808 S1813
6. C.A. Ferreira, W.V. Vicente, and P.R. Evora Assessment of aprotinin in the reduction of inflammatory systemic response in children undergoing surgery with cardiopulmonary bypass Rev Bras Cir Cardiovasc 25 2010 85 98
7. T.Y. Hsia, T.C. McQuinn, and R. Mukherjee Effects of aprotinin or tranexamic acid on proteolytic/cytokine profiles in infants after cardiac surgery Ann Thorac Surg 89 2010 1843 1852
8. G.J. Despotis, M.S. Avidan, and C.W. Hogue Jr Mechanisms and attenuation of hemostatic activation during extracorporeal circulation Ann Thorac Surg 72 2001 S1821 S1831
9. L.K. Davies Cardiopulmonary bypass in infants and children: how is it different? J Cardiothorac Vasc Anesth 13 1999 330 345 (Pubitemid 29283388)
10. C.C. D'Errico, H.M. Munro, and E.L. Bove Pro: the routine use of aprotinin during pediatric cardiac surgery is a benefit J Cardiothorac Vasc Anesth 13 1999 782 784 (Pubitemid 30007483)
11. D.T. Mangano, I.C. Tudor, and C. Dietzel The risk associated with aprotinin in cardiac surgery N Engl J Med 354 2006 353 365 (Pubitemid 43145060)
12. K. Karkouti, W.S. Beattie, and K.M. Dattilo A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion- risk cardiac surgery Transfusion 46 2006 327 338 (Pubitemid 43334084)
13. D.A. Fergusson, P.C. Hebert, and C.D. Mazer A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 358 2008 2319 2331 (Pubitemid 351749156)
14. N.A. Guzzetta, F.M. Evans, and E.S. Rosenberg The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis Anesth Analg 108 2009 448 455
15. A. Manrique, E.H. Jooste, and B.A. Kuch The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass Anesth Analg 109 2009 45 52
16. R.D. Jaquiss, N.S. Ghanayem, M.C. Zacharisen, K.A. Mussatto, J.S. Tweddell, and S.B. Litwin Safety of aprotinin use and re-use in pediatric cardiothoracic surgery Circulation 106 2002 I90 I94
17. W. Dietrich Incidence of hypersensitivity reactions Ann Thorac Surg 65 6 Suppl 1998 S60 S64 discussion S746
18. G.D. Williams, C. Ramamoorthy, K. Pentcheva, M.G. Boltz, K. Kamra, and V.M. Reddy A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery Paediatr Anaesth 18 2008 812 819
19. S.D. Chiravuri, T. Voepel-Lewis, E.J. Devaney, and S. Malviya The use of aprotinin in children undergoing operative repair of isolated atrial septal defects Paediatr Anaesth 18 2008 145 150
20. C.L. Backer, A.M. Kelle, and R.D. Stewart Aprotinin is safe in pediatric patients undergoing cardiac surgery J Thorac Cardiovasc Surg 134 2007 1421 1426
21. D.M. Arnold, D.A. Fergusson, and A.K. Chan Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin Anesth Analg 102 2006 731 737
22. E.S. Schouten, A.C. van de Pol, A.N. Schouten, N.M. Turner, N.J. Jansen, and C.W. Bollen The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis Pediatr Crit Care Med 10 2009 182 190
23. K.W.G. Martin, T. Breuer, R. Lange, and P. Tassani The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients Anesth Analg 107 2008 1783 1790
24. K.J. Jenkins, K. Gauvreau, J.W. Newburger, T.L. Spray, J.H. Moller, and L.I. Iezzoni Consensus-based method for risk adjustment for surgery for congenital heart disease J Thorac Cardiovasc Surg 123 2002 110 118
25. A. Akcan-Arikan, M. Zappitelli, L.L. Loftis, K.K. Washburn, L.S. Jefferson, and S.L. Goldstein Modified RIFLE criteria in critically ill children with acute kidney injury Kidney Int 71 2007 1028 1035 (Pubitemid 46741996)
26. G.J. Schwartz, L.G. Feld, and D.J. Langford A simple estimate of glomerular filtration ratein full-term infants during the first year of life J Pediatr 104 1984 849 854 (Pubitemid 14119952)
27. L.P. Brion, A.R. Fleischman, C. McCarton, and G.J. Schwartz A simple estimate of glomerular filtration rate in low birth weight infants during the first year of life: noninvasive assessment of body composition and growth J Pediatr 109 1986 698 707 (Pubitemid 16028629)
28. K. Martin, T. Breuer, and R. Gertler Tranexamic acid versus ε-aminocaproic acid: efficacy and safety in paediatric cardiac surgery Eur J Cardiothorac Surg 39 2011 892 897
29. B.E. Miller, S.R. Tosone, and V.K. Tam Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations Ann Thorac Surg 66 1998 535 540 discussion 541 (Pubitemid 28410692)
30. G.D. Williams, S.L. Bratton, and C. Ramamoorthy Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery Anesth Analg 89 1999 57 64 (Pubitemid 29293309)
31. A. Székely, Z. Cserép, and E. Sápi Risks and predictors of blood transfusion in pediatric patients undergoing open heart operations Ann Thorac Surg 87 2009 187 197
32. J.W. Salvin, M.A. Scheurer, and P.C. Laussen Blood transfusion after pediatric cardiac surgery is associated with prolonged hospital stay Ann Thorac Surg 91 2011 204 210
33. J. Lacroix, P.C. Hebert, and J.S. Hutchison Transfusion strategies for patients in pediatric intensive care units N Engl J Med 356 2007 1609 1619 (Pubitemid 46631670)
34. A. Willems, K. Harrington, and J. Lacroix Comparison of two red-cell transfusion strategies after pediatric cardiac surgery: a subgroup analysis Crit Care Med 38 2010 649 656
35. A. Székely, E. Sápi, and T. Breuer Aprotinin and renal dysfunction after pediatric cardiac surgery Pediatr Anesthes 18 2008 151 159
36. S.K. Pasquali, M. Hall, and J.S. Li Safety of aprotinin in congenital heart operations: results from a large multicenter database Ann Thorac Surg 90 2010 14 21
37. A.P. Furnary, Y. Wu, L.F. Hiratzka, G.L. Grunkemeier, and U.S. Page 3rd Aprotinin does not increase the risk of renal failure in cardiac surgery patients Circulation 116 2007 I127 I133
38. K. Karkouti, D.N. Wijeysundera, T.M. Yau, S.A. McCluskey, G. Tait, and W.S. Beattie The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery Anesth Analg 110 2010 21 29
39. M. Scheurer, K. Gauvreau, P.C. Laussen, J.E. Mayer Jr, and J.W. Newburger Abstract 1936: the impact of aprotinin on outcomes in infants undergoing cardiac surgery in a large multi-institutional database Circulation 120 2009 S575
40. L.J. Dacey, J.J. Munoz, and Y.R. Baribeau Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors Northern New England Cardiovascular Disease Study Group Arch Surg 133 1998 442 447 (Pubitemid 28193531)